Ghent-based SpectaCell launches with €6 million to advance its cell analysis platform for immunotherapy development
SpectaCell, a new Ghent-based startup specialising in next-generation cell therapy analytics, has announced its official launch with €6 million in Seed funding. The company has spun out of imec, VIB and Ghent University. The round was led by imec.xpand, with participation from PMV’s Flanders Future
<p>SpectaCell, a new Ghent-based startup specialising in next-generation cell therapy analytics, has announced its official launch with €6 million in Seed funding. The company has spun out of imec, VIB and Ghent University. The round was led by imec.xpand, with participation from PMV’s Flanders Future</p>